Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its growth and the impact of its CEO's health on the company's performance [3][4]. Summary by Relevant Sections Allegations - The complaint claims that C3.ai's management provided overly positive statements while concealing material adverse facts about the company's growth, particularly the CEO's health affecting deal closures [3]. - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [3]. Stock Price Impact - Following the announcement of poor financial results, C3.ai's stock price dropped significantly from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [3]. Class Action Details - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action, with a deadline of October 21, 2025, to seek lead plaintiff status [4]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. Law Firm Information - The Gross Law Firm, a nationally recognized class action law firm, is representing the shareholders, focusing on protecting investors from deceit and fraud [5].

Core Viewpoint - Neogen Corporation (NASDAQ: NEOG) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [3]. Group 1 - The class period for the lawsuit is from January 5, 2023, to June 3, 2025 [3]. - Allegations include that the defendants downplayed inefficiencies arising from the integration and assured investors of their commitment to resolving these issues quickly [3]. - Shareholders are encouraged to register for the class action by the deadline of September 16, 2025, to potentially become lead plaintiffs [4]. Group 2 - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

CONTACT US HERE: https://securitiesclasslaw.com/securities/c3-ai-inc-loss-submission-form-2/?id=166899&from=4 CLASS PERIOD: February 26, 2025 to August 8, 2025 ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of C3 AI's growth; notably, that its Chief Executive Officer health was having a significant i ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lineage, Inc. (NASDAQ: LINE). Shareholders who purchased shares of LINE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/lineage-inc-loss-submission-form/?id=166891&fro ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH). Shareholders who purchased shares of LNTH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/lantheus-holdings-inc-loss-submissio ...

Core Viewpoint - Tronox Holdings plc (NYSE: TROX) is facing a class action lawsuit due to allegations of providing misleading statements about its financial health and sales forecasts, leading to a significant drop in stock price following disappointing financial results [1][2]. Summary by Sections Allegations - The complaint claims that Tronox made overly positive statements while concealing adverse facts about its ability to forecast demand for its products, particularly in its commercial division [1]. - Despite optimistic long-term projections, the company's forecasting processes failed, resulting in declining sales and increased costs, which ultimately affected revenue projections [1]. Financial Impact - On July 30, 2025, Tronox reported a significant reduction in TiO2 sales, attributing the decline to a weaker coatings season and increased competition [1]. - Following the announcement, Tronox lowered its full-year revenue guidance and cut its dividend by 60%, leading to a dramatic stock price drop from $5.14 to $3.19 per share, a decline of approximately 38% in one day [1]. Class Action Details - Shareholders who purchased shares during the class period from February 12, 2025, to July 30, 2025, are encouraged to register for the class action, with a lead plaintiff deadline set for November 3, 2025 [2]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [2].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of LifeMD, Inc. regarding a class action lawsuit due to allegations of materially false and misleading statements made by the company during a specified class period [1]. Summary by Sections Allegations - The complaint alleges that during the class period from May 7, 2025, to August 5, 2025, LifeMD's management overstated the company's competitive position [1]. - It is claimed that the company recklessly raised its 2025 guidance without properly accounting for increasing customer acquisition costs in its RexMD segment and related to obesity treatment drugs like Wegovy and Zepbound [1]. - As a result, the statements made by the defendants regarding LifeMD's business, operations, and prospects were materially false and misleading [1]. Next Steps for Shareholders - Shareholders who purchased shares of LFMD during the specified timeframe are encouraged to register for the class action by October 25, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - Nutex Health Inc. is facing allegations of issuing materially false and misleading statements during the class period from August 8, 2024, to August 14, 2025, related to its financial reporting and business practices [1]. Group 1: Allegations Against Nutex Health Inc. - The complaint alleges that Nutex's third-party vendor, HaloMD, engaged in fraudulent activities to defraud insurance companies, leading to unsustainable revenue [1]. - Nutex is accused of overstating its remediation efforts regarding material weaknesses in its internal controls over financial reporting [1]. - The company improperly classified stock-based compensation obligations as equity instead of liabilities, increasing the risk of delayed financial report filings with the SEC [1]. Group 2: Class Action Details - Shareholders who purchased shares of Nutex during the specified class period are encouraged to register for the class action, with a deadline of October 21, 2025, to seek lead plaintiff status [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of PubMatic, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions that affected the company's stock value during a specified period [1][2]. Group 1: Allegations and Impact - The class period for the allegations is from February 27, 2025, to August 11, 2025 [2]. - Allegations include that a major demand side platform buyer shifted clients to a new platform, leading to a reduction in ad spend and revenue for PubMatic [2]. - The complaint asserts that the defendants made materially false and misleading statements about the company's business and prospects, lacking a reasonable basis [2]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of October 20, 2025, to potentially be appointed as lead plaintiffs [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to deceitful practices by companies [4]. - The firm emphasizes the importance of responsible business practices and corporate citizenship [4].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against RxSight, Inc. for allegedly misleading shareholders regarding the company's performance and financial guidance during a specified class period [2][4]. Summary by Relevant Sections Allegations - The complaint claims that RxSight faced "adoption challenges" and structural issues leading to declines in sales and utilization [2]. - It is alleged that the company overstated the demand for its products [2]. - As a result of these issues, RxSight is unlikely to meet its previously issued financial guidance for fiscal year 2025 [2]. - The positive statements made by the defendants about the company's business and prospects were materially misleading and lacked a reasonable basis [2]. Class Period and Deadlines - The class period for the lawsuit is from November 7, 2024, to July 8, 2025 [2]. - Shareholders are encouraged to register for the class action by September 22, 2025, to be eligible for potential recovery [3]. Next Steps for Shareholders - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].